These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1971110)

  • 1. Chronic exposure to flumazenil: anxiolytic effect and increased exploratory behavior.
    Urbancic M; Gadek MA; Marczynski TJ
    Pharmacol Biochem Behav; 1990 Mar; 35(3):503-9. PubMed ID: 1971110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic administration of flumazenil (Ro 15-1788) enhances non-appetitive exploratory behavior of rats.
    Marczynski TJ; Urbancic M; Gadek M
    Neuropharmacology; 1991 Oct; 30(10):1085-94. PubMed ID: 1661862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flumazenil blockade of anxiety following ethanol withdrawal in rats.
    Moy SS; Knapp DJ; Criswell HE; Breese GR
    Psychopharmacology (Berl); 1997 Jun; 131(4):354-60. PubMed ID: 9226737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug challenges reveal differences in mediation of stress facilitation of voluntary alcohol drinking and withdrawal-induced anxiety in alcohol-preferring P rats.
    Overstreet DH; Knapp DJ; Breese GR
    Alcohol Clin Exp Res; 2007 Sep; 31(9):1473-81. PubMed ID: 17624999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiolytic effect of Proproten under conditions of punished and unpunished behavior.
    Voronina TA; Molodavkin GM; Sergeeva SA; Epstein OI
    Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():120-2. PubMed ID: 12949673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral effects of diazepam in the murine plus-maze: flumazenil antagonism of enhanced head dipping but not the disinhibition of open-arm avoidance.
    Dalvi A; Rodgers RJ
    Pharmacol Biochem Behav; 1999 Apr; 62(4):727-34. PubMed ID: 10208379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal.
    Prather PL; Rezazadeh SM; Lane JD; Rowan GA; Hooper ML; Lytle DA; Emmett-Oglesby MW; Lal H
    J Pharmacol Exp Ther; 1993 Feb; 264(2):622-30. PubMed ID: 8094750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signaling.
    Klodzinska A; Tatarczyńska E; Chojnacka-Wójcik E; Nowak G; Cosford ND; Pilc A
    Neuropharmacology; 2004 Sep; 47(3):342-50. PubMed ID: 15275823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiogenic effects of the intraamygdala injection of flumazenil, a benzodiazepine receptor antagonist.
    Da Cunha C; Wolfman C; Levi de Stein M; Ruschel AC; Izquierdo I; Medina JH
    Funct Neurol; 1992; 7(5):401-5. PubMed ID: 1338052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.
    Pellow S; File SE
    Pharmacol Biochem Behav; 1986 Mar; 24(3):525-9. PubMed ID: 2871560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic administration of flumazenil increases life span and protects rats from age-related loss of cognitive functions: a benzodiazepine/GABAergic hypothesis of brain aging.
    Marczynski TJ; Artwohl J; Marczynska B
    Neurobiol Aging; 1994; 15(1):69-84. PubMed ID: 8159265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anxiolytic-like effect of 5-HT1B receptor ligands in rats: a possible mechanism of action.
    Chojnacka-Wójcik E; Kłodzińska A; Tatarczyńska E
    J Pharm Pharmacol; 2005 Feb; 57(2):253-7. PubMed ID: 15720791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic flumazenil (Ro 15-1788) facilitates acquisition and retention of a swim-escape response in rats.
    Urbancic M; Gadek M; Marczynski TJ
    Neuropsychobiology; 1990-1991; 24(1):17-24. PubMed ID: 2132637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
    Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
    Pharmacol Biochem Behav; 2004 Oct; 79(2):279-90. PubMed ID: 15501303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological evaluation of the anxiolytic-like effects of EMD 386088, a partial 5-HT6 receptor agonist, in the rat elevated plus-maze and Vogel conflict tests.
    Jastrzębska-Więsek M; Siwek A; Partyka A; Kubacka M; Mogilski S; Wasik A; Kołaczkowski M; Wesołowska A
    Neuropharmacology; 2014 Oct; 85():253-62. PubMed ID: 24905144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological analysis of the effects of benzodiazepines on punished schedule-induced polydipsia in rats.
    Pellón R; Ruíz A; Lamas E; Rodríguez C
    Behav Pharmacol; 2007 Feb; 18(1):81-7. PubMed ID: 17218801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between LY354740, a group II metabotropic agonist and the GABA(A)-benzodiazepine receptor complex in the rat elevated plus-maze.
    Ferris P; Seward E; Dawson GR
    J Psychopharmacol; 2001 Jun; 15(2):76-82. PubMed ID: 11448091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anxiolytic effect of gamma-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil.
    Schmidt-Mutter C; Pain L; Sandner G; Gobaille S; Maitre M
    Eur J Pharmacol; 1998 Jan; 342(1):21-7. PubMed ID: 9544788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sacred Maya incense, copal (Protium copal - Burseraceae), has antianxiety effects in animal models.
    Merali Z; Cayer C; Kent P; Liu R; Cal V; Harris CS; Arnason JT
    J Ethnopharmacol; 2018 Apr; 216():63-70. PubMed ID: 29414121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of presynaptic 5-HT(1A) and benzodiazepine receptors in the anticonflict activity of 5-HT(1A) receptor antagonists.
    Wesołowska A; Paluchowska M; Chojnacka-Wójcik E
    Eur J Pharmacol; 2003 Jun; 471(1):27-34. PubMed ID: 12809949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.